Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 53: 24-33, 2007. First published November 2, 2006; 10.1373/clinchem.2006.074856
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow 074856.Supplemental Data
Right arrow All Versions of this Article:
clinchem.2006.074856v1
53/1/24    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blievernicht, J. K.
Right arrow Articles by Zanger, U. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blievernicht, J. K.
Right arrow Articles by Zanger, U. M.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2007;53:24-33.)
© 2007 American Association for Clinical Chemistry, Inc.

Molecular Diagnostics and Genetics

MALDI-TOF Mass Spectrometry for Multiplex Genotyping of CYP2B6 Single-Nucleotide Polymorphisms

Julia K. Blievernicht1, Elke Schaeffeler1, Kathrin Klein1, Michel Eichelbaum1,2, Matthias Schwab1 and Ulrich M. Zanger1,a

1 Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
2 Division of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany.

aAddress correspondence to this author at: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Auerbachstr. 112, 70376 Stuttgart, Germany. Fax 49-(0)711-85-92-95; e-mail uli.zanger{at}ikp-stuttgart.de.

Background: CYP2B6 is a highly variable and polymorphic cytochrome P450 (CYP) enzyme involved in the biotransformation of an increasing number of drugs, including cyclophosphamide, bupropion, and the nonnucleosidic reverse transcriptase inhibitor efavirenz. Several nonsynonymous and promoter single-nucleotide polymorphisms (SNPs) in the CYP2B6 gene are associated with altered hepatic expression and function, which affect drug plasma concentrations.

Methods: We used multiplex PCR to amplify relevant gene fragments while avoiding amplification of the CYP2B7P1 pseudogene. Polymorphic sites were analyzed by allele-specific primer extension followed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Method evaluation was performed on a panel of 287 genomic DNA samples previously genotyped by other methods.

Results: Five multiplex assays were developed, comprising the following 15 SNPs: –82T->C (*22); 86G->C (R29T, *17); 136A->G (M46V, *11); 296G->A (G99E, *12); 415A->G (K139E, *8, *13); 419G->A (R140Q, *14); 516G->T (Q172H, *6, *7, *9, *13, *19, *20), 547G->A (V183I); 769G->A (D257N); 785A->G (K262R, *4, *6, *7, *13, *16, *19, *20); 983T->C (I328T, *16, *18); 1006C->T (R336C, *19); 1172T->A (I391N, *15); 1282C->A (P428T, *21); 1459C->T (R487C, *5, *7). In 9 DNA samples showing discrepant genotypes, correctness of the MALDI-TOF MS result was confirmed by direct sequencing.

Conclusions: This genotyping method enabled sensitive, specific, accurate, and comprehensive determination of 15 relevant SNPs of CYP2B6. The assay design allows analysis of SNP subsets, incorporation of additional SNPs, and performance of high-throughput genotyping.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
E. Schaeffeler, U. M. Zanger, M. Eichelbaum, S. Asante-Poku, J.-G. Shin, and M. Schwab
Highly Multiplexed Genotyping of Thiopurine S-Methyltransferase Variants Using MALDI-TOF Mass Spectrometry: Reliable Genotyping in Different Ethnic Groups
Clin. Chem., October 1, 2008; 54(10): 1637 - 1647.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. H. Hofmann, J. K. Blievernicht, K. Klein, T. Saussele, E. Schaeffeler, M. Schwab, and U. M. Zanger
Aberrant Splicing Caused by Single Nucleotide Polymorphism c.516G>T [Q172H], a Marker of CYP2B6*6, Is Responsible for Decreased Expression and Activity of CYP2B6 in Liver
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 284 - 292.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. C.H. Tsang, P. Charoenkwan, K. C.K. Chow, Y. Jin, C. Wanapirak, T. Sanguansermsri, Y.M. D. Lo, and R. W.K. Chiu
Mass Spectrometry Based Detection of Hemoglobin E Mutation by Allele-Specific Base Extension Reaction
Clin. Chem., December 1, 2007; 53(12): 2205 - 2209.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.